c albicans reference strain sc5314 (ATCC)
98
Structured Review
ATCC
c albicans reference strain sc5314
C Albicans Reference Strain Sc5314, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 585 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+albicans+reference+strain+sc5314/Candida+albicans+(Robin)+Berkhout/pm41898717-158-0-7
Average 98 stars, based on 585 article reviews
C Albicans Reference Strain Sc5314, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 585 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+albicans+reference+strain+sc5314/Candida+albicans+(Robin)+Berkhout/pm41898717-158-0-7
Average 98 stars, based on 585 article reviews
c albicans reference strain sc5314 - by Bioz Stars,
2026-09
98/100 stars
Images
Related Articles
Vaccines:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Enzyme-linked Immunosorbent Assay:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Transformation Assay:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Adjuvant:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Binding Assay:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Bioprocessing:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Flow Cytometry:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Expressing:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Confocal Microscopy:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Staining:Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans . Article Snippet: Article Title: Nature-Derived Ferulic Acid Hybrids with Enhanced Antifungal and Antivirulence Activity Against Candida albicans Article Snippet: Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. Article Snippet: FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.FluoroSpots in the unstimulated wells of each 787 mouse were subtracted from the antigen-stimulated spot counts and graphed.. 788 Infectious Inoculum Preparation 789 The C. albicans reference strain SC5314 ( Article Title: Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections Article Snippet: The C. albicans reference strain SC5314 ( Article Title: Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates Article Snippet: Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Candida auris clinical isolates AR-0381 (CAU-01), AR-0382 (CAU-02), AR-0383 (CAU-03), AR-0384 (CAU-04), AR-0385 (CAU-05), AR-0386 (CAU-06), AR-0389 (CAU-09) were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis Article Snippet: C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. Article Snippet: Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).Candida isolates and culture conditions C. auris clinical isolate AR-0389 (CAU-09) was supplied by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).. Article Title: Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection Article Snippet: Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).Two antifungal-resistant isolates of C. auris , AR-0386 (CAU-06) and AR-0389 (CAU-09), were supplied by the United States Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA).. |